Ferritin heavy chain (FTH1) exerts significant antigrowth effects in breast cancer cells by inhibiting the expression of c‐MYC

Overexpression of ferritin heavy chain (FTH1) often associates with good prognosis in breast cancer (BCa), particularly in the triple‐negative subtype (triple‐negative breast cancer). However, the mechanism by which FTH1 exerts its possible tumor suppressor effects in BCa is not known. Here, we exam...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Amjad Ali, Jasmin Shafarin, Rola Abu Jabal, Nour Aljabi, Mohamad Hamad, Jibran Sualeh Muhammad, Hema Unnikannan, Mawieh Hamad
פורמט: Artigo
שפה:Inglês
יצא לאור: Wiley 2021-11-01
סדרה:FEBS Open Bio
נושאים:
breast cancer
c‐MYC
FTH1
G9a
iron metabolism
גישה מקוונת:https://doi.org/10.1002/2211-5463.13303
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים